ArticleAIDS research and therapy2024

Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV.

Zhenyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.